Department of Pediatrics, University of Kentucky Medical School, Lexington, KY 40536, USA.
Arterioscler Thromb Vasc Biol. 2011 Nov;31(11):2543-51. doi: 10.1161/ATVBAHA.111.234716.
Scavenger receptor BI (SR-BI) is a high-density lipoprotein (HDL) receptor. Recent studies revealed that SR-BI protects against sepsis via modulating innate immunity. However, its role in adaptive immunity is unclear.
SR-BI-null mice exhibited impaired lymphocyte homeostasis as shown by splenomegaly and imbalanced expansion of T and B lymphocytes in the spleens. Importantly, the activated T and B lymphocytes were increased 3- to 4-fold, indicating a heightened active status of T and B lymphocytes. More importantly, in line with the accumulation of the activated T and B lymphocytes, SR-BI-null mice developed systemic autoimmune disorders characterized by the presence of autoantibodies in circulation, the deposition of immune complexes in glomeruli, and the leukocyte infiltration in kidney. Further analyses revealed that SR-BI deficiency enhanced lymphocyte proliferation, caused imbalanced interferon-γ and interleukin-4 production in lymphocytes, and caused elevated inflammatory cytokine production in macrophages. Furthermore, HDL from SR-BI-null mice exhibited less capability of suppressing lymphocyte proliferation.
SR-BI regulates lymphocyte homeostasis, likely through its roles in modulating the proliferation of lymphocytes, the cytokine production by lymphocytes and macrophages, and the function of HDL. Its deficiency leads to impaired lymphocyte homeostasis and autoimmune disorders. Our findings reveal a previously unrecognized role of SR-BI in adaptive immunity.
清道夫受体 BI(SR-BI)是一种高密度脂蛋白(HDL)受体。最近的研究表明,SR-BI 通过调节先天免疫来防止败血症。然而,其在适应性免疫中的作用尚不清楚。
SR-BI 基因敲除小鼠表现出淋巴细胞稳态受损,表现为脾肿大和脾脏中 T 淋巴细胞和 B 淋巴细胞的不平衡扩增。重要的是,激活的 T 和 B 淋巴细胞增加了 3-4 倍,表明 T 和 B 淋巴细胞处于高度活跃状态。更重要的是,与激活的 T 和 B 淋巴细胞的积累一致,SR-BI 基因敲除小鼠发展出全身性自身免疫性疾病,其特征是循环中存在自身抗体、免疫复合物在肾小球中的沉积以及白细胞浸润肾脏。进一步的分析表明,SR-BI 缺乏增强了淋巴细胞的增殖,导致淋巴细胞中干扰素-γ和白细胞介素-4 的产生失衡,并导致巨噬细胞中炎症细胞因子的产生升高。此外,来自 SR-BI 基因敲除小鼠的 HDL 显示出抑制淋巴细胞增殖的能力降低。
SR-BI 调节淋巴细胞稳态,可能通过其在调节淋巴细胞增殖、淋巴细胞和巨噬细胞产生细胞因子以及 HDL 功能中的作用。其缺乏导致淋巴细胞稳态受损和自身免疫性疾病。我们的研究结果揭示了 SR-BI 在适应性免疫中的一个以前未被认识的作用。